After stratification of the cancer patients according to their clinical stages, plasma visfatin was significantly upregulated in Stage IV colon cancer when compared with that in normal controls, Stage I–II, Stage III, and Stage I–III combined. This evidence concerns the gene NAMPT and colonic neoplasm.